Hamrick Investment Counsel, llc
Source: SEC Form 13F · as of Mar 2026Hamrick Investment Counsel, llc holds 21 biotech & pharma companies tracked by BioSniper, totaling $9.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$9.1M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 9,826 | $3.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,509 | $2.0M |
| PFEPFIZER INC | 53,146 | $1.5M |
| JNJJOHNSON & JOHNSON | 4,849 | $1.2M |
| NEOGNEOGEN CORP | 28,234 | $262K |
| BMYBRISTOL MYERS SQUIBB CO | 4,141 | $251K |
| MRKMerck & Co., Inc. | 1,650 | $200K |
| LLYELI LILLY & Co | 135 | $124K |
| ABBVAbbVie Inc. | 185 | $40K |
| SNYSanofi | 450 | $22K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 68 | $18K |
| GEHCGE HealthCare Technologies Inc. | 258 | $18K |
| NVSNovartis AG | 100 | $15K |
| ABTABBOTT LABORATORIES | 55 | $6K |
| CRSPCRISPR Therapeutics AG | 80 | $4K |
| NVONovo Nordisk A/S | 90 | $3K |
| IDXXIDEXX LABORATORIES INC /DE | 5 | $3K |
| OGNOrganon & Co. | 89 | $534 |
| CAHCardinal Health Inc. | 2 | $423 |
| ATAIAtai Beckley N.V. | 100 | $354 |
| GALTGALECTIN THERAPEUTICS INC | 100 | $279 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.